References:
- OPTN/SRTR 2018 annual data report: Introduction. Am J Transplant.
2020;20 Suppl s1(s1):11–9.
- Brull SJ, Naguib M. Selective reversal of muscle relaxation in general
anesthesia: focus on sugammadex. Drug Des Devel Ther. 2009;3:119–29
- Hristovska A-M, Duch P, Allingstrup M, Afshari A. Efficacy and safety
of sugammadex versus neostigmine in reversing neuromuscular blockade
in adults. Cochrane Database Syst Rev. 2017;8:CD012763.
- De Kam P-J, Grobara P, Prohn M, Höppener F, Kluft C, Burggraaf J, et
al. Effects of sugammadex on activated partial thromboplastin time and
prothrombin time in healthy subjects. Int J Clin Pharmacol Ther.
2014;52(3):227–36.
- Mueller A, Platz K, Kremer B. Early postoperative complications
following liver transplantation. Best Pract Res Clin Gastroenterol.
2004;18(5):881–900.
- Taner CB, Willingham DL, Bulatao IG, Shine TS, Peiris P, Torp KD, et
al. Is a mandatory intensive care unit stay needed after liver
transplantation? Feasibility of fast-tracking to the surgical ward
after liver transplantation. Liver Transpl. 2012;18(3):361–9.
- Everson GT. A hepatologist’s perspective on the management of
coagulation disorders before liver tranplantation. Liver Transpl Surg.
1997;3(6):646–52.
- Roberts LN, Patel RK, Arya R. Haemostasis and thrombosis in liver
disease. Br J Haematol. 2010;148(4):507–21.
- Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N
Engl J Med. 2011;365(2):147–56.
- Rahe-Meyer N, Fennema H, Schulman S, Klimscha W, Przemeck M, Blobner
M, et al. Effect of reversal of neuromuscular blockade with sugammadex
versus usual care on bleeding risk in a randomized study of surgical
patients. Anesthesiology. 2014;121(5):969–77.
- Summary of product characteristics, Bridion. 2015. Fda.gov. [cited
2021 Jan 18]. Available from:
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022225lbl.pdf
- Dirkmann D, Britten MW, Pauling H, Weidle J, Volbracht L, Görlinger K,
et al. Anticoagulant effect of Sugammadex: Just an in vitro artifact.
Anesthesiology. 2016;124(6):1277–85.
- De Kam P-J, El Galta R, Kruithof AC, Fennema H, van Lierop M-J, Mihara
K, et al. No clinically relevant interaction between sugammadex and
aspirin on platelet aggregation and coagulation parameters. Int J Clin
Pharmacol Ther. 2013;51(12):976–85.
- De Kam P-J, Kruithof AC, van Lierop M-J, Moerland M, Dennie J, Troyer
MD, et al. Lack of a clinically relevant effect of sugammadex on
anti-Xa activity or activated partial thromboplastin time following
pretreatment with either unfractionated or low-molecular-weight
heparin in healthy subjects. Int J Clin Pharmacol Ther.
2014;52(8):631–41.
- Taş N, Korkmaz H, Yağan Ö, Korkmaz M. Effect of sugammadex on
postoperative bleeding and coagulation parameters after septoplasty: A
randomized prospective study. Med Sci Monit. 2015;21:2382–6.
- Raft J, Betala Belinga JF, G J, Desandes E, Longrois D, Meistelman C.
Clinical evaluation of post-surgical bleeding after a sugammadex
injection. Ann Fr Anesth Reanim 2011; 30:714
- Moon Y-J, Kim S-H, Kim J-W, Lee Y-K, Jun I-G, Hwang G-S. Comparison of
postoperative coagulation profiles and outcome for sugammadex versus
pyridostigmine in 992 living donors after living-donor hepatectomy.
Medicine (Baltimore). 2018;97(11):e0129.
- Levitsky J, Goldberg D, Smith AR, Mansfield SA, Gillespie BW, Merion
RM, et al. Acute rejection increases risk of graft failure and death
in recent liver transplant recipients. Clin Gastroenterol Hepatol.
2017;15(4):584-593.e2.
- Rezonja K, Sostaric M, Vidmar G, Mars T. Dexamethasone produces
dose-dependent inhibition of sugammadex reversal in in vitro
innervated primary human muscle cells. Anesth Analg.
2014;118(4):755–63.
- Rezonja K, Mars T, Jerin A, Kozelj G, Pozar-Lukanovic N, Sostaric M.
Dexamethasone does not diminish sugammadex reversal of neuromuscular
block - clinical study in surgical patients undergoing general
anesthesia. BMC Anesthesiol. 2016;16(1):101
- Arslantas R, Cevik BE. Retrospective investigation of grafted kidney
function after reversal of neuromuscular blockade using neostigmine or
sugammadex. Transplant Proc. 2019;51(7):2265–7.
- Deljou A, Schroeder DR, Ballinger BA, Sprung J, Weingarten TN. Effects
of sugammadex on time of first postoperative bowel movement: A
retrospective analysis. Mayo Clin Proc Innov Qual Outcomes.
2019;3(3):294–301.